Trial Profile
Effects of Symbicort [budesonide/formoterol] single inhaler therapy on bronchial hyper responsiveness, asthma control and safety in mild to moderate asthmatics in general practice, compared to usual care therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 22 Nov 2005 New trial record.